Antiarthritic Effects of Sorafenib in Rats with Adjuvant‐Induced Arthritis
Authors:
- 12 May 2018
- journal article
- research article
- Published by Wiley in The Anatomical Record
- Vol. 301 (9) , 1519-1526
Abstract
Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting the synovial membrane of joints. In this study, we aimed to investigate whether sorafenib exerts antiarthritic effects on RA in vivo. Adjuvant arthritis (AA) was induced (day 0) in male Sprague–Dawley rats by intradermal injection of 0.1 mL of complete Freund's complete adjuvant into the left hind paw. Sorafenib (10, 20, or 40 mg/kg/day) was administered intragastrically from day 10 to 24. Body weight, paw volume, synovial inflammation, and tumor necrosis factor alpha (TNF‐α), interleukin‐1β (IL‐1β), IL‐10, and IL‐17 serum levels were detected. In addition, microvascular density (MVD) and the expression of vascular endothelial growth factor receptor 2 (VEGFR‐2) and fibroblast growth factor receptor 1 (FGFR‐1) in synovial tissues were analyzed. Our data revealed that sorafenib administration led to significant body weight gain in AA rats but suppressed paw swelling, synovial hyperplasia, and inflammatory infiltration. Furthermore, it decreased TNF‐α, IL‐1β, and IL‐17 serum levels and upregulated IL‐10. MVD and VEGFR‐2 and FGFR‐1 expression in synovial tissues were significantly reduced. Thus, this study shows that sorafenib exerts anti‐arthritic effects in AA rats and therefore has potential in RA treatment. Anat Rec, 301:1519–1526, 2018.Keywords
Funding Information
- the Natural Science Research Project of Anhui Higher Education (KJ 2017A188)
This publication has 35 references indexed in Scilit:
- Sorafenib prolongs liver regeneration after hepatic resection in ratsJournal of Surgical Research, 2013
- Fibroblast growth factor 2 is a key determinant of vascular sprouting during bovine luteal angiogenesisReproduction, 2012
- Sorafenib: complexities of Raf-dependent and Raf-independent signaling are now unveiledMedical Molecular Morphology, 2011
- Basic and Therapeutic Aspects of AngiogenesisCell, 2011
- Sorafenib induces apoptotic cell death in human non-small cell lung cancer cells by down-regulating mammalian target of rapamycin (mTOR)-dependent survivin expressionBiochemical Pharmacology, 2011
- Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experienceAngiogenesis, 2011
- Structure–function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signalingBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2010
- Evidence that cytokines play a role in rheumatoid arthritisJournal of Clinical Investigation, 2008
- Mechanism of Fibroblast‐Like Synoviocyte Apoptosis Induced by Recombinant Human Endostatin in Rats with Adjuvant ArthritisThe Anatomical Record, 2008
- Uncoupling of inflammation and destruction in rheumatoid arthritis: Myth or reality?Arthritis & Rheumatism, 2005